Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Pakistan · Delayed Price · Currency is PKR

904.28

+4.28 (0.48%)

At close: Aug 20, 2026

-22.72% (1Y)

Market Cap	88.11B -23.1%
Revenue (ttm)	75.76B +9.0%
Net Income	8.31B +56.3%
EPS	84.85 +56.3%
Shares Out	97.90M
PE Ratio	10.61
Forward PE	7.65
Dividend	40.00 (4.44%)
Ex-Dividend Date	Apr 22, 2026

Volume	9,956
Open	914.80
Previous Close	900.00
Day's Range	899.00 - 914.80
52-Week Range	821.00 - 1,304.00
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; and import and marketing of nutritional products. It also imports and markets diagnostic equipment, m... [Read more]

Industry Pharmaceuticals

Sector Healthcare

Founded 1888

Employees 1,380

Stock Exchange Pakistan Stock Exchange

Ticker Symbol ABOT

Full Company Profile

Financial Performance

In 2025, PSX:ABOT's revenue was 75.40 billion, an increase of 10.59% compared to the previous year's 68.18 billion. Earnings were 7.97 billion, an increase of 52.20%.

Financial Statements